Eleos Raises $60M in Series C Funding to Expand AI Solutions for Behavioral Health
Eleos specializes in developing AI solutions for behavioral health, empowering care providers with tools that improve efficiency, engagement, and outcomes.
Company Name: Eleos
Location: Boston, MA
Industry: Health tech
Funding Details:
Amount: $60M (Series C)
Total Funding to Date: $120M
Investors:
- Lead Investor: Greenfield Partners
- Existing Investors: F-Prime Capital, Eight Roads, Menlo Ventures, ION
- New Investors: Michael & Susan Dell Foundation, Union Tech Ventures, Centerstone
Purpose of Investment:
The funding will be used to:
- Accelerate new product offerings.
- Expand hiring.
- Increase presence in more behavioral health settings and markets.
Leadership:
CEO: Alon Joffe
Product:
Eleos provides AI-powered solutions designed to enhance behavioral healthcare. Key features include:
- Proprietary AI Technology: Leverages a dataset of real-world treatment sessions to drive insights and optimize care delivery.
- Multimodal Large Language Models (MM-LLMs): Processes multiple data input types simultaneously for comprehensive analysis.
- Progress Note Automation: Reduces note submission times by more than 80%, according to a recent randomized controlled trial (RCT).
- Client Engagement and Care Outcomes: Improves engagement and care outcomes by 3-4x compared to treatment as usual (TAU).
About the Company:
Eleos specializes in developing AI solutions for behavioral health, empowering care providers with tools that improve efficiency, engagement, and outcomes. By integrating advanced AI models and leveraging real-world treatment data, Eleos transforms how behavioral healthcare is delivered, making it more effective and scalable.
